143 related articles for article (PubMed ID: 14526983)
1. Review of methods and computer codes for interpretation of bioassay data.
Ansoborlo E; Bérard P; Eckerman K; Berkovski V; Birchall A; Fry F; Guilmette R; Miller G; Ishigure N; Lipsztein J; Nosske D
Radiat Prot Dosimetry; 2003; 105(1-4):341-6. PubMed ID: 14526983
[TBL] [Abstract][Full Text] [Related]
2. Reliability of the ICRP's dose coefficients for members of the public. III. Plutonium as a case study of uncertainties in the systemic biokinetics of radionuclides.
Leggett RW
Radiat Prot Dosimetry; 2003; 106(2):103-20. PubMed ID: 14653331
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of 239Pu inhalation doses calculated with ICRP 67 and proposed systemic models.
Li WB; Oeh U; Paretzke HG
Radiat Prot Dosimetry; 2007; 127(1-4):148-52. PubMed ID: 17545662
[TBL] [Abstract][Full Text] [Related]
4. A computational study of the urinary excretion rates for 339Pu using new ICRP internal dosimetry models.
Singh IS; Sharma RC; Abani MC
Radiat Prot Dosimetry; 2003; 105(1-4):361-4. PubMed ID: 14526987
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
[TBL] [Abstract][Full Text] [Related]
6. Risk estimates for deterministic health effects of inhaled weapons grade plutonium.
Scott BR; Peterson VL
Health Phys; 2003 Sep; 85(3):280-93. PubMed ID: 12938719
[TBL] [Abstract][Full Text] [Related]
7. Two case studies of highly insoluble plutonium inhalation with implications for bioassay.
Carbaugh EH; La Bone TR
Radiat Prot Dosimetry; 2003; 105(1-4):133-8. PubMed ID: 14526943
[TBL] [Abstract][Full Text] [Related]
8. Minimum detectable dose as a measure of bioassay programme capability.
Carbaugh EH
Radiat Prot Dosimetry; 2003; 105(1-4):391-4. PubMed ID: 14526994
[TBL] [Abstract][Full Text] [Related]
9. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: a parameter sensitivity analysis.
Huston TE; Farfán EB; Bolch WE; Bolch WE
Health Phys; 2003 Nov; 85(5):553-66. PubMed ID: 14571988
[TBL] [Abstract][Full Text] [Related]
10. Eliminating bias in routine bioassay when there is an unknown time of intake.
Strom DJ
Radiat Prot Dosimetry; 2003; 105(1-4):339-40. PubMed ID: 14526982
[TBL] [Abstract][Full Text] [Related]
11. Practical experience of the application of ICRP models in internal dose assessment.
Peace MS
Radiat Prot Dosimetry; 2003; 105(1-4):33-8. PubMed ID: 14526923
[TBL] [Abstract][Full Text] [Related]
12. The application of Bayesian techniques in the interpretation of bioassay data.
Miller G; Little T; Guilmette R
Radiat Prot Dosimetry; 2003; 105(1-4):333-8. PubMed ID: 14526981
[TBL] [Abstract][Full Text] [Related]
13. IMPDOS (improved dosimetry and risk assessment for plutonium-induced diseases): internal dosimetry software tools developed for the Mayak worker study.
Miller G; Bertelli L; Guilmette R
Radiat Prot Dosimetry; 2008; 131(3):308-15. PubMed ID: 18658175
[TBL] [Abstract][Full Text] [Related]
14. Structure of a physiologically based biokinetic model for use in 14C and organically bound tritium dosimetry.
Whillans DW
Radiat Prot Dosimetry; 2003; 105(1-4):189-91. PubMed ID: 14526954
[TBL] [Abstract][Full Text] [Related]
15. Lessons learnt from an international intercomparison of national network systems used to provide early warning of a nuclear accident.
Sáez-Vergara JC; Thompson IM; Funck E; Andersen CE; Neumaier S; Bøtter-Jensen L
Radiat Prot Dosimetry; 2003; 103(3):197-210. PubMed ID: 12678381
[TBL] [Abstract][Full Text] [Related]
16. EURADOS work on internal dosimetry.
Breustedt B; Blanchardon E; Castellani CM; Etherington G; Franck D; Giussani A; Hofmann W; Lebacq AL; Li WB; Noßke D; Lopez MA
Ann ICRP; 2018 Oct; 47(3-4):75-82. PubMed ID: 29664321
[TBL] [Abstract][Full Text] [Related]
17. Modifying the ICRP 66 dosimetry model based on results obtained from Mayak plutonium workers.
Romanov SA; Guilmette RA; Hahn FF; Nifatov AP; Zaytseva YV; Lyovkina YV
Radiat Prot Dosimetry; 2003; 105(1-4):85-90. PubMed ID: 14526933
[TBL] [Abstract][Full Text] [Related]
18. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: particle clearance.
Bolch WE; Huston TE; Farfán EB; Vernetson WG; Bolch WE
Health Phys; 2003 Apr; 84(4):421-35. PubMed ID: 12705441
[TBL] [Abstract][Full Text] [Related]
19. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
[TBL] [Abstract][Full Text] [Related]
20. Considerations on the ICRP model predictions of the transfer of (137)Cs from food to the milk and urine of lactating mothers.
Giussani A; Risica S
J Radiol Prot; 2014 Jun; 34(2):N19-30. PubMed ID: 24705367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
